![Jounce Therapeutics](https://s33007.pcdn.co/wp-content/uploads/2020/02/Jounce-Therapeutics-Logo.png)
Jounce Therapeutics, Inc. (NASDAQ: JNCE) is a clinical-stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients through a biomarker-driven approach. Jounce currently has multiple development stage programs ongoing while simultaneously advancing additional early-stage assets from its robust discovery engine based on its Translational Science Platform.